文献速递生殖医学

基于水凝胶的紧凑型高通量半自动胚胎玻璃化冷冻系统

A compact, high-throughput semi-automated embryo vitrification system based on hydrogel.
PubMed 文献 · Reprod Biomed Online · 2023-12-11

本研究为比较性实验室内研究,使用小鼠模型和人第6天囊胚,评估基于水凝胶的Biorocks半自动玻璃化冷冻系统的效率与效果。该系统实现溶液交换自动化,处理通量可达每小时36个卵母细胞/胚胎,12个容器可同时处理;小鼠卵母细胞存活率Biorocks组98%(n=46)与Cryotop手动法95%(n=39)相当,人第6天CC级囊胚2小时再扩张率Biorocks组92%(n=39)与Cryotop组90%(n=30)相当。作者认为该系统提高通量且不损害存活与发育潜能,但需进一步研究在更广泛临床背景下的效果。

要点

  • Biorocks系统自动化溶液交换,通量可达每小时36个卵母细胞/胚胎,12个容器同时处理。
  • 小鼠卵母细胞存活率Biorocks组98%(n=46) vs Cryotop组95%(n=39),无显著差异描述。
  • 人第6天CC级囊胚2小时再扩张率Biorocks组92%(n=39) vs Cryotop组90%(n=30)。

核心结论

  • Biorocks半自动玻璃化冷冻系统提高通量且不损害卵母细胞和胚胎的存活与发育潜能。
  • 作者认为该系统可能有助于提高辅助生殖技术诊所中玻璃化冷冻的效率和标准化。
  • 作者指出需进一步研究以确认其在更广泛临床背景下的效果。

研究设计与样本

  • 比较性实验室内研究,使用小鼠模型和人第6天囊胚。
  • 小鼠卵母细胞和胚胎在玻璃化冷冻后进行质量评估。

主要发现

  • Biorocks系统成功自动化玻璃化冷冻过程中的溶液交换,通量可达每小时36个卵母细胞/胚胎。
  • 使用水凝胶递送冷冻保护剂,12个容器可同时处理,可舒适地置于辅助生殖技术工作站内。
  • 小鼠卵母细胞存活率Biorocks组98%(n=46) vs Cryotop手动法组95%(n=39),体外受精后第5天进展至囊胚的比例分别为46%和41%。
  • 人第6天CC级囊胚经Biorocks系统处理(n=39)的2小时再扩张率为92%,Cryotop组(n=30)为90%。
  • Biorocks系统的冷却速率和升温速率分别为31,900°C/分钟和24,700°C/分钟。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文指出需进一步研究以确认该系统在更广泛临床背景下的效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: What is the efficiency and efficacy of the novel Biorocks semi-automated vitrification system, which is based on a hydrogel? DESIGN: This comparative experimental laboratory study used mouse model and human day 6 blastocysts. Mouse oocytes and embryos were quality assessed post-vitrification. RESULTS: The Biorocks system successfully automated the solution exchanges during the vitrification process, achieving a significantly improved throughput of up to 36 embryos/oocytes per hour. Using hydrogel for cryoprotective agent delivery, 12 vessels could be processed simultaneously, fitting comfortably within an assisted reproductive technology (ART) workstation. In tests involving the cryopreservation of oocytes and embryos, the system yielded outcomes equivalent to the manual Cryotop method. For example, the survival rate for mouse oocytes was 98% with the Biorocks vitrification system (n = 46) and 95% for the manual Cryotop method (n = 39), of which 46% and 41%, respectively, progressed to blastocysts on day 5 after IVF. CC-grade day 6 human blastocysts processed with the Biorocks system (n = 39) were associated with a 92% 2 h re-expansion rate, equivalent to the 90% with Cryotop (n = 30). The cooling/warming rates achieved by the Biorocks system were 31,900°C/minute and 24,700°C/minute, respectively. Oocyte quality was comparable or better post-vitrification for Biorocks than Cryotop. CONCLUSIONS: The Biorocks semi-automated vitrification system offers enhanced throughput without compromising the survival and developmental potential of oocytes and embryos. This innovative system may help to increase the efficiency and standardization of vitrification in ART clinics. Further investigations are needed to confirm its efficacy in a broader clinical context.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Wang S, Chen L, Fang J, et al. A compact, high-throughput semi-automated embryo vitrification system based on hydrogel. Reprod Biomed Online. 2023. PMID: 38492415. doi:10.1016/j.rbmo.2023.103769

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。